
Stoked Bio is a drug discovery and development company focused on creating novel therapeutics for untreatable diseases, particularly infections and cancers resistant to current treatments. They leverage cutting-edge AI for identifying new treatment options, improving drug candidates by refining scaffolds, and developing new drugs for resistant bacterial, fungal, and cancer indications. Their approach combines experimental and computational methods, with a philosophy of "biologists first" using AI as a tool to solve biological problems. Stoked Bio aims to fill the pipeline for new drugs by developing novel therapies with new mechanisms of action to combat drug-resistant diseases and improve global public health. They are a self-sustaining, world-class Canadian drug research and development organization building collaborations and concentrating on revenue-generating partnerships.

Stoked Bio is a drug discovery and development company focused on creating novel therapeutics for untreatable diseases, particularly infections and cancers resistant to current treatments. They leverage cutting-edge AI for identifying new treatment options, improving drug candidates by refining scaffolds, and developing new drugs for resistant bacterial, fungal, and cancer indications. Their approach combines experimental and computational methods, with a philosophy of "biologists first" using AI as a tool to solve biological problems. Stoked Bio aims to fill the pipeline for new drugs by developing novel therapies with new mechanisms of action to combat drug-resistant diseases and improve global public health. They are a self-sustaining, world-class Canadian drug research and development organization building collaborations and concentrating on revenue-generating partnerships.